Charles A. Weiss is a partner in Holland & Knight's New York office and head of the New York Intellectual Property Group. He concentrates his practice on technology-driven litigation, counseling and transactions, primarily in the pharmaceutical, chemical and biotechnology areas. He also counsels clients on questions of patent validity and infringement, and provides a litigator's perspective on prosecution matters.
Mr. Weiss litigates patent, trade secret, license and false advertising cases in diverse technical areas. He has handled cases over the years involving expression of recombinant proteins and antibodies, controlled release pharmaceuticals, medical diagnostic agents, endocrine and hormone products, nutritional supplements, industrial control systems, food chemistry, nucleic acid diagnostic assays and commercial detergents. He also has extensive experience in the investigation of product counterfeiting and pursuit of those responsible.
Mr. Weiss also has a diverse non-litigation practice focused on supporting transactions in which a substantial value is attributed to a party's patent position, such as its ability to exclude competitors or to bring its product to market free of meritorious infringement claims by others. He negotiates and drafts licenses and other agreements, including commercial collaboration, joint research and product acquisition agreements, and regularly advises financial professionals on the strength or vulnerability of a target company's patent positions.
Mr. Weiss also has experience in commercial matters, including corporate and securities transactions, contract litigation, insurance and banking disputes, construction litigation, accounting and attorney malpractice, and investigations of employee malfeasance and fraud. Mr. Weiss is an associate adjunct professor at Brooklyn Law School, where he designed and teaches a course on food and drug law.
Eric Huang is a partner in Quinn Emanuel's New York office. He represents both plaintiffs and defendants in intellectual property matters. He specializes in building patent infringement cases on either side of the “v” in highly technical subject matter. He has extensive experience litigating patent cases involving a wide range of technologies – smartphones, user interface software, touchscreen technology, circuits, semiconductor processing, spreading and modulation techniques used in wireless communication, various aspects of 3G and 4G cellular communications, error control coding including turbocodes and low density parity check codes, digital video compression, audio compression, pharmaceutical formulations, fiber optics, liquid crystal displays, mechanical measurement devices, electronic engine control, e-commerce, and computer systems.
His practice encompasses all aspects of case preparation, pre-trial discovery, expert preparation, trial preparation and trial in U.S. federal district courts and before the U.S. International Trade Commission. He served as a trial counsel for respondent Samsung in ITC investigation 337-TA-796 initiated by Apple against Samsung's smartphones, tablets and media players. The firm successfully defended against efforts to stop the importation of Samsung devices; to date, no Samsung device was excluded or seized as a result of any order from this investigation. Eric recently helped secure a very favorable jury verdict for Marvell Semiconductor in a case brought by France Telecom in San Francisco federal district court alleging infringement by Marvell’s 3G baseband chips. In addition to a favorable damages verdict of a fraction of the damages sought by plaintiff, the firm recently secured judgment for Marvell Semiconductor on post-trial motions in that case. Eric also has experience prosecuting patents and is admitted to the U.S. Patent & Trademark Office.
Eric’s representative clients include BlackBerry, California Institute of Technology, Canon, Marvell Semiconductor, MediaTek, Monolithic Power Systems, Motorola, Reliant Pharmaceuticals, Rovi, Samsung, and Sony.
Prior to joining Quinn Emanuel, Eric was an associate with the law firm of Fish & Neave and served as a law clerk to the Honorable Eric Bruggink on the U.S. Court of Federal Claims (1997-1998). He is a 1997 graduate of the George Washington University Law School, and has a materials science & engineering degree from the University of Michigan in Ann Arbor. Prior to law school, Eric worked for National Semiconductor in California as an electronic packaging engineer. He currently serves on the Board of Directors of the New York Lawyers for the Public Interest and the Board of Trustees for the Blue School, a private independent school in New York City.
John Hintz is a Shareholder in Maynard Cooper’s New York office and a member of the firm’s Intellectual Property Litigation and Intellectual Property Protection practice groups. He has 30 years of experience handling intellectual property matters, and in particular, patent litigation. John has worked on all aspects of patent disputes and has litigated in federal courts throughout the country and before the International Trade Commission.
John also has significant transactional, licensing, and counseling experience, including advising clients on the IP aspects of IPOs, mergers and acquisitions, and the transfer and licensing of IP assets. His clients span a broad range of industries covering diverse technologies, including search engines, financial services, semiconductors, barcode scanning, Internet-related businesses and technologies, telecommunications, computer simulations, commodity chemicals, polymers, process control instruments, medical devices, and life sciences.
John served as Samsung's expert witness on U.S. law related to patents and patent licensing in disputes between Samsung and Apple in the Netherlands, France, Italy, Japan and Australia. John began his IP career and became a partner at the preeminent IP litigation law firm Fish & Neave.
BestLawyers® 2013 “Lawyer of the Year” for Patent Litigation
New York Super Lawyers for Intellectual Property Litigation (2006-present)
IAM Patent 1000, The World’s Leading Practitioners, 2014-present
Who’s Who in Legal for Patents, 2014-present
AV Preeminent® rating in Martindale-Hubbell
State Bar: New York
U.S. Supreme Court
U.S. Court of Appeals: Federal Circuit
U.S. District Court: Colorado, New York (Eastern, Southern, Western), Texas (Eastern, Western), Wisconsin (Eastern, Western
U.S. Patent & Trademark Office
The George Washington University Law School (J.D. (with honors), Law Review)
Miami University (Ohio) (B.S.)
Keith Zullow, a partner in Goodwin's IP Litigation Group, is a U.S. registered patent attorney with significant trial experience in chemical and pharmaceutical patent litigation. He is also experienced in interference practice and trade secret litigation. Mr. Zullow has worked on cases in various federal district courts throughout the United States, on appeals before the U.S. Court of Appeals for the Federal Circuit and other circuit courts, and is lead counsel on proceedings before the Patent Trial and Appeal Board.
J.D., New York University School of Law, 1994
B.S., Chemical Engineering, Cornell University, 1987 (with distinction)
Mr. Zullow is admitted to practice in New York, as well as before the U.S. Supreme Court, the U.S. Court of Appeals for the Federal Circuit, and the U.S. District Courts for the Southern and Eastern Districts of New York. He is also admitted to practice before the U.S. Patent and Trademark Office.
Sarah A. Solomon is a partner in the firm’s Technology & Life Sciences Group.
Ms. Solomon represents biotechnology, pharmaceutical, medical device, diagnostic and other life sciences companies in connection with their intellectual property, commercial and M&A transactions. She regularly advises private and public companies on complex strategic collaboration and partnering transactions (such as co-development, joint research and development agreements, patent licenses, strategic alliances and joint ventures); research, development and commercial relationships (such as manufacturing, distribution, supply, clinical trial, university licenses and services arrangements); and mergers and acquisitions (such as product acquisitions, spin-outs and patent portfolio acquisitions). Ms. Solomon also counsels clients in connection with international transactions and relationships in North America, South America, Europe and Asia.
J.D., University of California Hastings College Law, 2001
B.S., Biology, University of California, San Diego, 1996
Bar and Court Admissions
Ms. Solomon is admitted to practice in California.
Karen Mangasarian is a partner and intellectual property lawyer with Foley & Lardner LLP. She counsels biotechnology, pharmaceutical, and other life sciences clients on all aspects of intellectual property, including procurement and management of worldwide patent rights, patent life cycle management, development of competitive patent strategies, licensing, IP due diligence, and validity, patentability, non-infringement, and freedom-to-operate analyses. She also has extensive experience in contentious patent matters, including interferences, re-examinations, oppositions, and litigation. Dr. Mangasarian has successfully worked with clients across a wide range of technology areas in life sciences including small molecule pharmaceuticals, pharmaceutical formulations, antibodies, protein therapeutics, CRISPR and diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics, and computational biology. She is a member of the firm’s Chemical, Biotech & Pharmaceutical Practice.
Prior to joining Foley, Dr. Mangasarian was a partner at a major New York City-based law firm.
Dr. Mangasarian was recognized among IAM Patent 1000 – World’s Leading Patent Practitioners (2014 – 2016).
JD, magna cum laude, New York Law School, 2000
PhD (Pharmacology), University of Wisconsin-Madison, 1992
BS (Biochemistry), University of Wisconsin-Madison, 1984
U.S. Patent and Trademark Office
Clients look to Chris for his background in patent prosecution and counseling, with an emphasis on high technology intellectual property matters.
Chris’ responsiveness to client needs and experience handling large and complex projects have helped produce successful outcomes in patent preparation, litigation, and examination. He also has an outstanding track record in patent post-grant procedures such as inter partes review, re-examination, and supplemental examination. Chris’ intellectual property portfolio management experience encompasses planned acquisition, due diligence related to portfolio acquisition, and auditing of existing patent portfolios.
Representative technologies in the electrical and computer arts include:
• Display and imaging devices
• Electronic commerce
• Electrical circuitry
Prior to joining Michael Best, Chris worked as a patent examiner and senior counsel for a multinational corporation. He lectures and writes regularly on the spectrum of patent issues for the Practicing Law Institute, where he also mentors lawyers on advanced patent prosecution.